Melatonin alleviates BDE-209-induced cognitive impairment and hippocampal neuroinflammation by modulating microglia polarization via SIRT1-mediated HMGB1/TLR4/NF-κB pathway

Food Chem Toxicol. 2023 Feb:172:113561. doi: 10.1016/j.fct.2022.113561. Epub 2022 Dec 22.

Abstract

Polybrominated diphenyl ethers (PBDEs) are persistent environmental contaminants with developmental neurotoxicity, the mechanism of which remains obscure. The present study aimed to evaluate cognitive deficits and microglia-originated neuroinflammation in the hippocampus of offspring rats exposed to BDE-209 (30 and 100 mg/kg) during perinatal period. Compared to the control, BDE-209-treated rats showed significant longer escape latency and less platform crossings in tests of Morris water maze. Besides obvious hippocampal neuron damage, increased microglial activation and pro-inflammatory markers (CD86, TNFα, and IL-1β), meanwhile, decreased anti-inflammatory molecules (CD206, IL-10, and Arg1) were induced by BDE-209. Furthermore, we investigated the neuroprotection of melatonin against BDE-209 and whether through sirtuin 1 (SIRT1). Consistent with restored SIRT1 activity, enhanced deacetylation of HMGB1 and inhibited cytoplasmic translocation of HMGB1, reduced expression of proteins involved in TLR4-NF-κB pathway and nuclear transfer of phosphorylated-NF-κB p65, and ultimately suppressed microglial activation and improved spatial memory were observed in 10 mg/kg melatonin-pretreated rats, compared with BDE-209-exposed alone. These results demonstrated that melatonin ameliorated BDE-209-caused cognitive impairment partially through shifting microglia polarization towards anti-inflammatory phenotype in a SIRT1-dependent manner, suggesting a potential mechanism for prevention.

Keywords: Decabromodiphenyl ether; Melatonin; Microglia; Sirtuin 1; Spatial memory.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Cognitive Dysfunction* / chemically induced
  • Cognitive Dysfunction* / drug therapy
  • Cognitive Dysfunction* / metabolism
  • HMGB1 Protein* / metabolism
  • Halogenated Diphenyl Ethers / metabolism
  • Halogenated Diphenyl Ethers / toxicity
  • Hippocampus / metabolism
  • Melatonin* / pharmacology
  • Melatonin* / therapeutic use
  • Microglia / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Neuroinflammatory Diseases
  • Rats
  • Sirtuin 1 / metabolism
  • Toll-Like Receptor 4 / genetics
  • Toll-Like Receptor 4 / metabolism

Substances

  • NF-kappa B
  • decabromobiphenyl ether
  • Halogenated Diphenyl Ethers
  • Sirtuin 1
  • Melatonin
  • Toll-Like Receptor 4
  • HMGB1 Protein
  • Anti-Inflammatory Agents
  • Sirt1 protein, rat
  • Tlr4 protein, rat